Electrical and pharmacological strategies for early cardioversion of atrial fibrillation;Elektrische und pharmakologische frühkardioversion von vorhofflimmern

Herzschrittmachertherapie und Elektrophysiologie

Volumn 17, Issue 2, 2006, Pages 81-88

  Linhart, M ^a   Lewalter, T ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Atrial fibrillation; Early cardioversion; Electrical cardioversion; Pharmacological cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DIGOXIN; DISOPYRAMIDE; DOFETILIDE; ENOXAPARIN; FLECAINIDE; HEPARIN; IBUTILIDE; LOW MOLECULAR WEIGHT HEPARIN; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

CARDIOVERSION; DEFIBRILLATOR; ELECTROCARDIOGRAM; ENERGY; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; PROGNOSIS; REVIEW; SINUS RHYTHM; THROMBOEMBOLISM; TREATMENT INDICATION;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 33745307141     PISSN: 09387412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00399-006-0514-0     Document Type: Review

References (40)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama 285:2370-2375
2. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:1231-1266
3. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH (1989) Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 63:193-197
4. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833
5. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840
6. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41:1690-1696
7. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373-2383
8. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Jr., Raisch DW, Ezekowitz MD (2005) Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861-1872
9. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197-204
10. Viswanathan K, Daniak SM, Salomone K, Kiely T, Patel U, Converso K, Manning WJ, Silverman DI (2001) Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance. Am J Cardiol 88:439-441
11. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954-1968
12. Pandozi C, Bianconi L, Villani M, Gentilucci G, Castro A, Altamura G, Jesi AP, Lamberti F, Ammirati F, Santini M (1998) Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 98:2860-2865
13. Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B (1997) Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med 126:621-625
14. Galve E, Rius T, Ballester R, Artaza MA, Arnau JM, Garcia-Dorado D, Soler-Soler J (1996) Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 27:1079-1082
15. Tejan-Sie SA, Murray RD, Black IW, Jasper SE, Apperson-Hansen C, Li J, Lieber EA, Grimm RA, Klein AL (2003) Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: an ACUTE trial ancillary study. J Am Coll Cardiol 42:1638-1643
16. Schwartzman D, Musley S, Koehler J, Warman E (2005) Impact of atrial fibrillation duration on postcardioversion recurrence. Heart Rhythm 2:1324-1329
17. Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Bocker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275-1279
18. Kirchhof P, Borggrefe M, Breithardt G (2003) Effect of electrode position on the outcome of cardioversion. Card Electrophysiol Rev 7:292-296
19. Siaplaouras S, Buob A, Rotter C, Bohm M, Jung J (2005) Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation. Am Heart J 150:150-152
20. Adgey AA, Walsh SJ (2004) Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion. Heart 90:1493-1498
21. Kirchhof P, Monnig G, Wasmer K, Heinecke A, Breithardt G, Eckardt L, Bocker D (2005) A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBI-PAPA). Eur Heart J 26:1292-1297
22. Gurevitz OT, Ammash NM, Malouf JF, Chandrasekaran K, Rosales AG, Ballman KV, Hammill SC, White RD, Gersh BJ, Friedman PA (2005) Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter. Am Heart J 149:316-321
23. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB (2000) Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101:1282-1287
24. Ricard P, Levy S, Trigano J, Paganelli F, Daoud E, Man KC, Strickberger SA, Morady F (1997) Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 79:815-816
25. Nichol G, McAlister F, Pham B, Laupacis A, Shea B, Green M, Tang A, Wells G (2002) Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 87:535-543
26. Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WG (1997) Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med 127:281-284
27. Lewalter T, Nickenig G (2006) [Pharmacotherapy of supraventricular arrhythmias.]. Internist (Berl) 47:80-88
28. McNamara RL, Tamariz LJ, Segal JB, Bass EB (2003) Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 139:1018-1033
29. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, Fernandez-Gomez JM, Santos JM, Camacho C (2000) Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 86:950-953
30. Tuseth V, Jaatun HJ, Dickstein K (2005) Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment. Heart 91:964-965
31. Hohnloser SH, Dorian P, Straub M, Beckmann K, Kowey P (2004) Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. J Am Coll Cardiol 44:99-104
32. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G (2004) Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med 351:2384-2391
33. Kirchhof P, Fetsch T, Hanrath P, Meinertz T, Steinbeck G, Lehmacher W, Breithardt G (2005) Targeted pharmacological reversal of electrical remodeling after cardioversion - rationale and design of the Flecainide Short-Long (Flec-SL) trial. Am Heart J 150:899
34. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ (1997) Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 126:615-620
35. Gallagher MM, Hennessy BJ, Edvardsson N, Hart CM, Shannon MS, Obel OA, Al-Saady NM, Camm AJ (2002) Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol 40:926-933
36. Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mugge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA (2004) Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 109:997-1003
37. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS (1994) Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23:1535-1540
38. Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G (2004) Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385-1394
39. Schuchert A (2003) Kommentar zu den ACC/AHA/ESC-Leitlinien 2001 zur Prävention arterieller Thromboembolien bei Patienten mit Vorhofflimmern. Z Kardiol 92:694-703
40. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 35:183-187